Expertise in
41
conditions

Jie X. Ma

China
Expertise in
41
conditions
Expertise in
41
conditions
OverviewLocationsClinical Research

Overview

Jie Ma practices in Zhengzhou, China. Ma is highly rated in 41 conditions, according to our data. Their top areas of expertise are Brachydactyly Type A2, Lung Cancer, Aplastic Anemia, Mastectomy, and Pancreaticoduodenectomy.

Their clinical research consists of co-authoring 1853 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

No. 100 Kexue Road, Zhengzhou, 450001, China
Other Locations
Pokfulam Road, Hong Kong, China
222 Tianshui South Road, Lanzhou, 730000, China
28 Fuxing Road, Haidian, 100853, China
NO. 1200, Cailun Road, Shanghai, 201203, China
Shenzhen Branch, Shenzhen, China
Peking Union Medical College Hospital, Beijing, 100010, China
6 Shuangyong Road, Nanning, 530021, China
No 127, Dongming Road, Zhengzhou, 450008, China
No. 3, East Street, Yongding Road, Haidian, 100039, China
No. 1 Xinmin Road, Changchun, 130021, China
Peking Union Medical College Hospital, Peking Union Medical College, Beijing, China
28 West Xianning Street, Xi'an, 710000, China
219 Miaopu Road, Shanghai, 200135, China
No.1, East Jianshe Road, Zhengzhou, 450052, China
No. 30 Science Park Road, Zhong Guan Cun Life Science Park, Changping, 102206, China
Yangtze River Fisheries Research Institute, Wuhan, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Controlled, Open-label, Multicenter Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)
A Randomized, Controlled, Open-label, Multicenter Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)
Enrollment Status: Active_not_recruiting
Publish Date: February 20, 2025
Intervention Type: Drug
Study Drugs: AK105 Injection, Anlotinib Hydrochloride Capsules, Sorafenib Tosylate Tablets
Study Phase: Phase 3
A Multicenter, Open-label, Single-arm, Phase II Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced HER2 Negative Breast Cancer
A Multicenter, Open-label, Single-arm, Phase II Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced HER2 Negative Breast Cancer
Enrollment Status: Terminated
Publish Date: February 23, 2024
Intervention Type: Drug
Study Drug: Mitoxantrone Hydrochloride
Study Phase: Phase 2
An Open, Single-center, Phase II Study of Sintilimab, Peg-aspargase Plus Anlotinib SandwichWith Radiotherapy in Previously Untreated Stage I-II Extranodal NK/T Cell Lymphoma
An Open, Single-center, Phase II Study of Sintilimab, Peg-aspargase Plus Anlotinib SandwichWith Radiotherapy in Previously Untreated Stage I-II Extranodal NK/T Cell Lymphoma
Enrollment Status: Completed
Publish Date: June 09, 2022
Intervention Type: Drug
Study Drug: Sintilimab
Study Phase: Phase 2
View 2 Less Clinical Trials

1853 Total Publications

Development and Validation of Risk Stratification for Heart Failure After Acute Coronary Syndrome Based on Dynamic S100A8/A9 Levels.
Development and Validation of Risk Stratification for Heart Failure After Acute Coronary Syndrome Based on Dynamic S100A8/A9 Levels.
Journal: Journal of the American Heart Association
Published: February 03, 2025

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this expert for later?
Sign Up
Looking for the best expert for you?
Start Here
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile